 |
 |
 |
| 24小時(shí)熱門(mén)版塊排行榜 |
- >論壇更新日志 (6379)
- >導(dǎo)師招生 (1393)
- >考研 (1277)
- >蟲(chóng)友互識(shí) (833)
- >文獻(xiàn)求助 (396)
- >考博 (254)
- >休閑灌水 (198)
- >碩博家園 (153)
- >基金申請(qǐng) (90)
- >論文投稿 (74)
- >公派出國(guó) (70)
- >論文道賀祈福 (66)
- >招聘信息布告欄 (61)
- >教師之家 (57)
- >博后之家 (54)
- >SciFinder/Reaxys (39)
 |
 |
 |
||
 |
 |
 |
 |
 |
| 1 | 1/1 | 返回列表 |
| 查看: 773 | 回復(fù): 0 | |||||||||||||||
samleomeivt新蟲(chóng) (初入文壇)
|
[交流]
美國(guó)弗吉尼亞理工大學(xué)Dr. Shenglin Mei實(shí)驗(yàn)室誠(chéng)聘計(jì)算生物學(xué)博士后，博士及科研助理
|
梅勝林課題組將于2024年12月在弗吉尼亞理工大學(xué)FBRI癌癥研究中心及華盛頓特區(qū)兒童國(guó)家醫(yī)學(xué)中心建立。課題組致力于研究腫瘤微環(huán)境在腫瘤侵襲和轉(zhuǎn)移過(guò)程中的重塑和調(diào)控機(jī)制。實(shí)驗(yàn)室結(jié)合單細(xì)胞和空間轉(zhuǎn)錄組測(cè)序技術(shù)、多組數(shù)據(jù)集、機(jī)器學(xué)習(xí)和實(shí)驗(yàn)方法，探討腫瘤微環(huán)境及基因調(diào)控因子如何控制腫瘤轉(zhuǎn)移。梅勝林博士在哈佛醫(yī)學(xué)院Peter Kharchenko和麻省總院David Sykes實(shí)驗(yàn)室接受博士后訓(xùn)練，并以第一/共一/共同通訊作者在Cancer Cell, Nature methods, Nat Commun, Journal of Hepatology, Genome Medicine等期刊發(fā)表論文14篇，獲得PCF Young Investigator Award 。歡迎具有生物信息學(xué)、生物學(xué)、計(jì)算機(jī)、物理、統(tǒng)計(jì)等相關(guān)專(zhuān)業(yè)的博士生和訪(fǎng)問(wèn)學(xué)者加盟。課題組位于首都華盛頓特區(qū)北部，氣候宜人，安全舒適，交通便利。 Several Postdoctoral Positions are available at Virginia Tech and Children’s National Hospital Dr. Shenglin Mei lab (https://shenglinmei.github.io/ ) at Fralin Biomedical Research Institute (FBRI) Cancer Research Center DC of Virginia Tech, and Children's National Center for Cancer and Immunology Research, is seeking highly motivated postdoctoral fellow and graduate students to join our team. The Mei Laboratory studies the remodeling and regulatory mechanisms of the tumor microenvironment during tumor progression and metastasis. The lab specializes in computational biology, and combines single-cell technologies, genomic datasets, machine learning, and experimental methods to investigate how the tumor microenvironment and gene regulatory factors control tumor metastasis cascade. By advancing our understanding of malignant cell heterogeneity and context-dependent tumor microenvironment remodeling, we aim to drive the development of novel therapeutic approaches for patients with metastatic cancer. The current focuses in lab include the following directions: 1) Developing computational methods for integrating multi-modal data, such as scRNA-seq, scATAC-seq, spatial transcriptomics, ChIP-seq, and CRISPR screening. 2) Investigating context-dependent remodeling of the tumor microenvironment. 3) Identifying novel regulators within the tumor microenvironment. 4) Exploring tumor organ specific metastasis with multi-omics data integration. The candidate will develop novel statistical and machine learning methods for multi-omics data integration and apply the computational methods to explore the dysregulation and regulation of tumor microenvironment, malignant cell heterogeneity, plasticity, and tumor immunology. Our lab is located in Children's National Research & Innovation Campus at Washington, D.C., and the positions offer a minimal annual salary of $68,000 and are adjustable based on research experience. About PI: Dr. Shenglin Mei is set to join the FBRI at Virginia Tech as tenure-track assistant professor in December 2024. He currently serves as an Instructor at the Center for Regenerative Medicine at Massachusetts General Hospital and Harvard Medical School. He earned his Ph.D. at Tongji University and the Dana-Farber Cancer Institute under the mentorship of Dr. Xiaole Shirley Liu, and completed his post-doc training in Department of Biomedical Informatics (DBMI) at Harvard Medical School with Dr. Peter Kharchenko , as well as at Massachusetts General Hospital with Dr. David Sykes. His research focuses on understanding tumor microenvironment remodeling and regulation through integrative genomics and experimental approaches. His lab will combine single cell technologies, genomic datasets, machine learning, and experimental approaches to address fundamental questions in tumor progression and metastasis cascade, with applications to uncover novel tumor microenvironment regulator, gain insights into tumor organ-specific metastasis, predict metastasis at early stage and develop new therapeutic targets. Dr. Mei authored over 38 publications, including 14 papers where he is a first/co-first author or co-corresponding author, published in highly internationally recognized journals such as Cancer Cell, Nature Methods, Journal of Hepatology, Genome Medicine et.al. He also received the Prostate Cancer Foundation Young Investigator Award. Preferred qualifications: • PhD and/or MD in computational biology, bioinformatics, genomics, biology, data science, computer science or other related fields. • Experience in high-throughput sequencing data analysis, knowledge in supervised and unsupervised machine learning, or deep learning models. • Strong programming skills in Python or R, and Linux Shell; experience in genomics data processing and open source repositories e.g. GitHub is a plus. • Track record of first/co-first-author original research papers. • Strong oral and written communication skills. How to Apply: Interested applicants should submit the following materials via email to Dr. Shenglin Mei (shenglinmei@vtc.vt.edu): 1) a cover letter describing current research activities and your interest in this position, 2) a current CV (including publications), and 3) contact information for three references. About Virginia Tech and Children’s National Hospital Virginia Tech, founded in 1872, is one of the top public universities in the United States. According to the latest US News university rankings, Virginia Tech ranks 47th overall for national universities and 20th among public universities, and have received high marks in engineering, computer science, architecture, and agriculture and biomedical science. Children’s National Hospital, based in Washington, D.C., has been serving the nation’s children since 1870. Children’s National is #6 overall, #1 for babies and ranked in every specialty evaluated by U.S. News & World Report for children’s hospital in the U.S. Children’s National is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels. As the capital of United States, Washington DC is the hub of American politics and history. Washington DC metropolitan area (including Virginia and Maryland) is the home of people from diverse backgrounds, and is considered one of the best places to live and work in US. |
回復(fù)此樓» 猜你喜歡
一志愿天津大學(xué)材料與化工275求調(diào)劑
已經(jīng)有22人回復(fù)
-
0703求調(diào)劑
已經(jīng)有5人回復(fù)
-
0857 資源與環(huán)境 285分
已經(jīng)有6人回復(fù)
-
材料工程,326分，求調(diào)劑
已經(jīng)有5人回復(fù)
-
301求調(diào)劑
已經(jīng)有5人回復(fù)
-
334求調(diào)劑
已經(jīng)有3人回復(fù)
-
材料與化工085600調(diào)劑求老師收留
已經(jīng)有5人回復(fù)
-
一志愿華科071000生物學(xué) 338求調(diào)劑
已經(jīng)有4人回復(fù)
-
290求調(diào)劑
已經(jīng)有4人回復(fù)
-
308求調(diào)劑
已經(jīng)有4人回復(fù)
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 samleomeivt 的主題更新
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料工程,326分，求調(diào)劑 +5 | KRSLSR 2026-03-10 | 5/250 |
|
|---|---|---|---|---|
|
[考博] 讀博申請(qǐng) +5 | 感dd 2026-03-10 | 7/350 |
|
|
|
[考研] 泣血叩求調(diào)劑恩，愿以丹心報(bào)師恩 +5 | Iuruoh 2026-03-11 | 5/250 |
|
|
|
[考研] 290求調(diào)劑 +3 | 柯淮然 2026-03-10 | 8/400 |
|
|
|
[考研] 哈工大材料324求調(diào)劑 +6 | 閆旭東 2026-03-10 | 8/400 |
|
|
|
[考研] 材料工程專(zhuān)碩，一志愿中國(guó)礦業(yè)大學(xué)，總分314，求調(diào)劑 +4 | 無(wú)懈可擊的巨人 2026-03-10 | 4/200 |
|
|
|
[考研] 收調(diào)劑 +7 | 調(diào)劑的考研學(xué)生 2026-03-10 | 7/350 |
|
|
|
[考研] 材料與化工，291，求調(diào)劑 +12 | 咕嚕咕嚕123123 2026-03-05 | 13/650 |
|
|
|
[考研] 化工284求調(diào)劑 +12 | 小黑想變白 2026-03-07 | 12/600 |
|
|
|
[考研] 085600材料與化工 326 求調(diào)劑 +4 | 熱愛(ài)生活ing 2026-03-09 | 4/200 |
|
|
|
[考研] 310 070300化學(xué)求調(diào)劑 +4 | 撲風(fēng)鈴的貓 2026-03-08 | 5/250 |
|
|
|
[考研] 296求調(diào)劑 +4 | Xinyu Wu311 2026-03-09 | 4/200 |
|
|
|
[考研] 083000環(huán)境科學(xué)與工程調(diào)劑 +5 | 加油呀fxy 2026-03-07 | 6/300 |
|
|
|
[教師之家] 交大前校長(zhǎng)王樹(shù)國(guó)：現(xiàn)在最先進(jìn)的科技并不在大學(xué)實(shí)驗(yàn)室，而是在企業(yè)研究院 +4 | zju2000 2026-03-08 | 6/300 |
|
|
|
[考研] 081700學(xué)碩一志愿北京化工大學(xué)數(shù)二英一過(guò)六級(jí)有競(jìng)賽求調(diào)劑 +5 | galaxary 2026-03-07 | 7/350 |
|
|
|
[考研] 一志愿武漢理工085601，初試301分，請(qǐng)問(wèn)能調(diào)劑到湖北嗎 +3 | 肖yang 2026-03-06 | 3/150 |
|
|
|
[考研] 275求調(diào)劑 +4 | 大爆炸難民 2026-03-06 | 5/250 |
|
|
|
[考研] 材料調(diào)劑 +5 | ws 上岸鴨 2026-03-05 | 5/250 |
|
|
|
[考研] 紡織、生物、化學(xué)、材料等專(zhuān)業(yè) +3 | Eember. 2026-03-05 | 7/350 |
|
|
|
[考研] 376求調(diào)劑 +3 | 王浩然sam 2026-03-04 | 3/150 |
|